Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. by Tosi M. Mwakyandile (16408705)

Serum concentrations of malondialdehyde (a) and super oxide dismutase (b) and NOx (nitrate +nitrite) (c) in different experimental groups on day 2 and 10. by Omid Mehrpour (9385929)

The concentration of inflammatory parameters (TNF-α and IL-10) in serum (a and b) and burned skin samples (c) of different experimental groups on day 2 and 10. by Omid Mehrpour (9385929)

The concentrations of malondialdehyde (a), super oxide dismutase (b), and NOx (nitrate +nitrite)(c) in the burned skin samples of different experimental groups on day 2 and 10. by Omid Mehrpour (9385929)

BRD4 regulates KSHV inducible gene expression in the TR dependent manner. by Tomoki Inagaki (12903779)

Schematic model of TR functions as an inducible enhancer for KSHV lytic gene transcription. by Tomoki Inagaki (12903779)

Establishment of cBu-1 BAC16 for the isolation of reactivated cell population. by Tomoki Inagaki (12903779)

Experimental workflow of the isolation and the comparison of reactivated cBu-1 TR21- and TR6-KSHV infected iSLK cells. by Tomoki Inagaki (12903779)

Generation of recombinant KSHV BAC with different numbers of TR copies. by Tomoki Inagaki (12903779)

LANA NBs functions as transcription memory. by Tomoki Inagaki (12903779)

BRD4 and LANA protein form LLPS. by Tomoki Inagaki (12903779)

Raw data used to preapre presented figures are listed in the file. by Tomoki Inagaki (12903779)

Primer and synthesized DNA fragments used in this study. by Tomoki Inagaki (12903779)

Renal (urea and creatinine) (a, b) and Liver function (ALT and AST) (c, d) test in serums of different experimental groups and body weight changes (e) on day 10. by Omid Mehrpour (9385929)

Ball valve pipeline geometric modeling. by Weiqing Xu (1279959)

“…<div><p>Hydrogen is a clean energy source, and blending it with natural gas in existing pipeline networks is a key transition solution for transportation cost reduction. …”